METHODS OF TREATING PHOSPHATE CONCENTRATION DISORDERS WITH L-BAIBA

METHODS OF TREATING SUBSTANCE ABUSE

DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES

EXTENDED RELEASE PHARMACEUTICAL FORMULATION AND METHODS OF TREATMENT

Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor

METHODS FOR TREATMENT OF BLADDER CANCER WITH GEMCITABINE

PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE

Method for removing keratotic plugs

USE OF CANNABINOIDS IN THE TREATMENT OF ORAL INFLAMMATION AND PERIODONTAL DISEASE

NUTRITIONAL COMPOSITIONS COMPRISING HYDROLYZED PROTEIN AND A MODIFIED FAT SYSTEM AND USES THEREOF

Products having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids

Compositions and methods for treatment of invasive cancers

GENETIC POLYMORPHISMS ASSOCIATED WITH VENOUS THROMBOSIS AND STATIN RESPONSE, METHODS OF DETECTION AND USES THEREOF

CHITOSAN DERIVATIVES AS ANTIMICROBIALS AND SYNERGISTIC COMBINATIONS THEREOF

METHODS OF TREATMENT USING OMALIZUMAB

Methods of Assessing Unbound PCSK9 or Effective PCSK9 Activity

ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES

CO-INHIBITION OF CD47/SIRPalpha BINDING AND NEDD8-ACTIVATING ENZYME E1 REGULATORY SUBUNIT FOR THE TREATMENT OF CANCER

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

INHIBITOR AGAINST EXPRESSION OF IMMUNE CHECKPOINT MOLECULE

NOTCH RECEPTORS WITH MINIMAL LINKER

Timosaponin compounds

CYCLIC DI-NUCLEOTIDE COMPOUNDS AND METHODS OF USE

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

Use of a DPP-4 inhibitor in SIRS and/or sepsis

IRAK degraders and uses thereof

KINASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE

MCL-1 inhibitors

Substituted indoline derivatives as dengue viral replication inhibitors

SILK FIBROIN-BASED MICRONEEDLES AND USES THEREOF

NASAL AND OPHTHALMIC DELIVERY OF AQUEOUS CORTICOSTEROID SOLUTIONS

TITANIA BASED GENERATORS FOR AC-225 GENERATION

PRO-CYCLIC DINUCLEOTIDES AND PRO-CYCLIC DINUCLEOTIDE CONJUGATES FOR CYTOKINE INDUCTION

VACCINE COMPOSITIONS COMPRISING C-C MOTIF CHEMOKINE 22 (CCL22) OR FRAGMENTS THEREOF

TREATMENT OF POST-TRAUMATIC STRESS DISORDER USING BOTULINUM TOXIN A

ADAMTS13 TREATMENT TO ENHANCE GRAFT SURVIVAL

A METHOD FOR TREATING TUMOR BY USING RECOMBINANT INTERFERON WITH CHANGED SPATIAL CONFIGURATION

ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS

DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION

Oncolytic poliovirus for human tumors

METHOD FOR REVERSING MULTIPLE RESISTANCE IN ANIMAL CELLS

BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS

Compositions and methods for transplantation of colon microbiota

SCAFFOLDS TO TREAT SOLID TUMOR CELLS AND ESCAPE VARIANTS

METHOD OF TREATING CANCER

METHODS OF TREATING OR SELECTING A TREATMENT FOR A SUBJECT RESISTANT TO TNF INHIBITOR USING A NLRP3 ANTAGONIST

POST COVID19 VACCINE REMEDIES

Synthetic progestogens and pharmaceutical compositions comprising the same

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

Formulations/Compositions Comprising a BTK Inhibitor

CYANO-SUBSTITUTED CYCLIC HYDRAZINE DERIVATIVE AND APPLICATION THEREOF

Compositions and Methods for Treating Cancer

PYRIDINYL INDOLE COMPOUNDS AND METHODS OF USE THEREOF

ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE SALT BLEND AND RELATED COMPOUNDS IN HUMANS

VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS, ELOVANOID HYDROXYLATED DERIVATIVES, AND METHODS OF USE

Vidofludimus for use in the treatment or prevention of viral diseases

METHODS FOR TREATING CANCER

2,4-dinitrophenol formulations and methods using same

POLYPEPTIDE FORMULATIONS

IMMEDIATE-RELEASE TABLETS CONTAINING A DRUG AND PROCESSES FOR FORMING THE TABLETS

Synthetic progestogens and pharmaceutical compositions comprising the same

Synthetic progestogens and pharmaceutical compositions comprising the same

Lung-targeted corticosteroid treatment in viral respiratory disease, COVID-19 and ARDS (acute respiratory distress syndrome)

POMEGRANATE OIL FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES

Orally administered corticosteroid compositions

FEED ADDITIVE COMPOSITIONS

METHODS AND COMPOSITIONS FOR OX40 ACTIVATION IN TREATMENT OF CANINE CANCER

HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY

NOVEL ANTI-ZIKA VIRUS ANTIBODIES AND USES THEREOF

Methods for treating muscle wasting and bone disease using novel hybrid ActRIIB ligand trap proteins

METHODS FOR TREATING MYELOPROLIFERATIVE DISORDERS

Substituted piperazines as BTK inhibitors

N2-phenylpyrimidine-2,4-diamine compounds, and preparation methods and methods of use thereof

NON-HYGROSCOPIC CRYSTALLINE SALTS OF A PYRAZOLE COMPOUND, AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF

Deuterated etoricoxib, methods of manufacture, and use thereof

PROTAC SMALL MOLECULE COMPOUND AND USE THEREOF

COMPOUNDS AND METHODS FOR THE TREATMENT AND PREVENTION OF FIBROTIC DISEASE STATES AND CANCER

COMPOSITIONS AND METHODS OF SUPPRESSING AVERSIVENESS OF PHARMACEUTICALS AND INGESTIBLE MATERIALS

Pharmaceutical compositions comprising meloxicam

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

AD35-vectored immunogenic composition for SARS-COV-2 infection

Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

IMMUNOACTIVE MICROPARTICLES AND USES THEREOF

Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides

ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS

Exosome-based cancer assays

ANTI-CANCER ONCOLYTIC VIRUS COMBINATION THERAPIES AND ELITE RESPONDER SELECTION PLATFORMS

TREATMENT METHODS USING ADENOVIRUS

Use of for recovery of microbiota dysbiosis in early life

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF PANCREATITIS

APPLICATION OF GLUCAN IN PREPARATION OF DRUG

CD73 INHIBITORS

TREATMENT OF TRAUMATIC ENCEPHALOPATHY BY FIBROBLASTS AND THERAPEUTIC ADJUVANTS

Combination therapies for the treatment of cancer

1-METHYLXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF

ANTIMALARIAL AGENTS

Pharmaceutical composition comprising macitentan for the treatment of chronic thromboembolic pulmonary hypertension

DOSAGE FORMS FOR TYK2 INHIBITORS

Ophthalmic compositions

DISPERSIBLE COMPOSITIONS

USE OF AN OREXIN 2 RECEPTOR AGONIST FOR THE TREATMENT OF EXCESSIVE SLEEPINESS

Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists

Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery

Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cations

Methods and compositions to prevent and treat disorders associated with mutations in the ODC1 gene

METHODS OF TREATING CANCER

STERICALLY STABILIZED CARRIER FOR SUBCUTANEOUS, SUBLINGUAL AND ORAL THERAPEUTICS, COMPOSITIONS AND METHODS FOR TREATING A MAMMAL

CONTROLLED RELEASE CORE-SHELL PARTICLES AND SUSPENSIONS INCLUDING THE SAME

COMPOSITIONS FOR ORAL MICROADHESIVE DOSAGE FORMS

GENETIC VARIANTS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE

COMPOSITIONS FOR REPROGRAMMING CELLS INTO DENDRITIC CELLS OR ANTIGEN PRESENTING CELLS, METHODS AND USES THEREOF

Antibodies against signal-regulatory protein alpha and methods of use

Anti-CD40 antibodies and uses thereof

Methods for the treatment of thyroid eye disease

USE OF THE ANTI-P-SELECTIN ANTIBODY CRIZANLIZUMAB FOR TREATING SICKLE CELL NEPHROPATHY AND CHRONIC KIDNEY DISEASE ASSOCIATED WITH SICKLE CELL DISEASE

COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR FOR TREATING CANCER

NOVEL ANTI-CD4 ANTIBODIES

ANTAGONISTS ANTI-CD7 ANTIBODIES

ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS

Peptide analogs

Treatment of cystic fibrosis by delivery of nebulized mRNA encoding CFTR

SMARCA INHIBITORS AND USES THEREOF

Macrocyclic compounds and uses thereof

Pharmaceutical compounds

Diacylglycerol kinase modulating compounds

3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors

CANCER TREATMENTS TARGETING CANCER STEM CELLS

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

Crystalline forms of CHClNO

PROSTAGLANDIN E2 RECEPTOR 4 ANTAGONISTS AND USES THEREOF

Compositions comprising oxo-derivatives of fatty acids and methods of making and using same

Swallowable drug delivery device and methods of drug delivery

METHODS OF TREATMENT OF NON-SMALL-CELL LUNG CARCINOMA USING TELISOTUZUMAB VEDOTIN

Ocular applications of silk-based products

HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74

DOSING AND ADMINISTRATION OF RECOMBINANT L-ASPARAGINASE

IL-22 ORAL, INTRA-RECTAL, OR OTHER GUT-RELATED COMPOSITIONS AND METHODS OF USE THEREOF

FOCAL TREATMENT OF PROSTATE CANCER

EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS FOR TREATMENT OF CANCER

Strontium based compositions and formulations for pain, pruritus, and inflammation

Pharmaceutical composition for treatment and prevention of chronic disease

USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF PAIN, AND CORRESPONDING COMPOSITIONS

Composition and use thereof in the manufacture of medicament for treating cancer

Antiviral supplement formulations

PHARMACEUTICAL COMBINATION AND USE THEREOF

Combination pharmaceutical agents as RSV inhibitors

Taurultam, taurinamide and methylene glycol treatment for MYC—expressing tumors in mammalian bodies

COMPOSITIONS AND METHODS FOR TREATING EYES AND METHODS OF PREPARATION

COMBINATION THERAPY FOR CANCER TREATMENT

Protein kinase C inhibitors for treatment of uveal melanoma

COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS

TREATMENT FOR DIABETES IN PATIENTS INAPPROPRIATE FOR METFORMIN THERAPY

CO-POTENTIATORS FOR THERAPY OF CYSTIC FIBROSIS CAUSED BY MINIMAL FUNCTION CFTR MUTANTS

Methods and compositions for treatment of epileptic disorders

OXATHIAZIN_DIOXIDE FOR TREATING, PREVENTING, INHIBITING OR REDUCING CYTOKINE RELEASE

Method for treating inflammatory disorders

L-pag derivatives for treatment of sleep disordered breathing (SDB)

FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE

COMPOSITIONS FOR THE TREATMENT OF SOLID TUMORS

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION USING ANTIVIRAL COCKTAILS

METHODS OF TREATING HYPERTRIGLYCERIDEMIA

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE

CREATINE, ITS DERIVATIVES, COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR SENSITIZING CANCER CELLS TO DRUG-INDUCED APOPTOSIS

USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY

SYNTHETIC LIPID-LIKE MATERIALS FOR BRAIN DELIVERY

ACTIVE SUBSTANCE DELIVERY SYSTEM WITH DELAYED DELIVERY

METAL (HYDR)OXIDE COMPOSITE COMPRISING POORLY SOLUBLE DRUG, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

ELONGATE FORM MEDICAMENT CARRIER AND MEDICAMENT DISPENSER

Drinkable Supplement Composition for Improved Health and Hydration

Methods of assigning a COVID pathological type based on a cytokine/chemokine panel

Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment

M1 VIRUS MUTANT AND USE THEREOF

METHODS OF MAKING OLIGOPOTENT AND UNIPOTENT PRECURSORS

METHOD FOR TRANSFORMING AN ESSENTIAL OIL

CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2

Treatment of Parkinson's Disease

POLYPEPTIDES AND USES THEREOF FOR TREATMENT OF AUTOIMMUNE DISORDERS AND INFECTION

Tau-protein targeting compounds and associated

INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF

NITRILOTRIACETIC ACID-CONTAINING LIPIDOID NANOPARTICLES

HOLDER FOR ADMINISTRATING RADIATION OR ANTICANCER CHEMOTHERAPY SENSITIZER

Pharmaceutical compositions comprising meloxicam

BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE

DOSING OF RECOMBINANT L-ASPARAGINASE

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

TARGETING MELANOCORTIN 3 RECEPTOR FOR TREATMENT/PREVENTION OF EATING, METABOLISM, AND/OR EMOTIONAL DISORDERS

SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

TERLIPRESSIN COMPOSITIONS AND THEIR METHODS OF USE

Transmucosal psychoactive alkaloid composition and preparation thereof

OXATHIAZIN COMPOUNDS FOR INHIBITING GAPDH

USE OF TREM-1 INHIBITORS FOR TREATMENT, ELIMINATION AND ERADICATION OF HIV-1 INFECTION

REDUCED CALORIC INTAKE AND ANTICANCER AGENTS FOR THE TREATMENT OF CANCER

CONTROLLED-RELEASE NICOTINE CHEWING GUM

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

METHOD OF TREATING LIVER FIBROSIS

Sulfasalazine salts, production processes and uses

BAX activators and uses thereof in cancer therapy

Methods for Increasing the Bioavailability of OTC and Pharmaceutical Drugs

NOVEL SUBSTITUTED SULFOXIMINE DERIVATIVES

BIOFILM DISRUPTION

TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM

TREATMENT OF BREAST CANCER

IMPLANTABLE CONSTRUCTS AND USES THEREOF

Imaging and Treatment Methods for Early Detection of Diseases

Generation of human allergen- and helminth-specific IgE monoclonal antibodies for diagnostic and therapeutic use

INHIBITION OF KMT2D FOR THE TREATMENT OF CANCER

USES OF SYNTHETIC LETHAL PARTNERS FOR TREATMENT OF CANCER

CELLULAR SEEDING AND CO-CULTURE OF A THREE DIMENSIONAL FIBROBLAST CONSTRUCT

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

NOVEL ANTI-CLDN18.2 ANTIBODIES

ANTI-CD38 ANTIBODY AND METHODS OF USE THEREOF

EPHA2 antibodies

CHIMERIC PROTEINS IN AUTOIMMUNITY

CYCLIC CELL PENETRATING PEPTIDES COMPRISING BETA-HAIRPIN MOTIFS AND METHODS OF MAKING AND USING THEREOF

PEPTIDE INHIBITORS OF FOCAL ADHESION KINASE ACTIVITY AND USES THEREOF

Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists

Deuterated angiotensin-converting enzyme-2 (ACE-2) inhibitors

Pharmaceutical compounds

TDO2 Inhibitors

FUSED HETEROAROMATIC PYRROLIDINONES

Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors

SUBSTITUTED 1,3-PHENYL HETEROARYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

GLP-1R modulating compounds

BEZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS

Crystalline freebase forms of a biphenyl compound

Biphenyl compounds useful as muscarinic receptor antagonists

Compositions For Preventing And/Or Treating Degenerative Disorders Of The Central Nervous System And/Or Lysosomal Storage Disorders

Methanol-based extraction of psychoactive alkaloids from fungus

NATURAL CANNABINOID COMBINATION THERAPY COMPOSITIONS AND METHODS FOR PERSONALIZED AND TARGETED THERAPIES INCLUDING THE TREATMENT OF INFECTIOUS DISEASES

COMPOSITIONS AND METHODS FOR DIAGNOSING VIRAL INFECTIONS INCLUDING COVID-19 AND FOR INFECTION SEVERITY MONITORING AS WELL AS TARGETED DETECTION OF CYTOKINE STORM

PHARMACEUTICAL COMPOSITION WHICH CAN BE USED FOR PREVENTION AND/OR TREATMENT OF ACQUIRED HEMOPHILIA A, AND PRODUCT COMPRISING SAID PHARMACEUTICAL COMPOSITION

CORE/SHELL STRUCTURE PLATFORM FOR IMMUNOTHERAPY

Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist for treatment of cancer

NK-lysin peptide compositions and methods for their use as antimicrobial/antiviral agents

MEDICAMENT AND FOOD FOR PREVENTING OR TREATING NOVEL CORONAVIRUS PNEUMONIA COVID-19 AND USE THEREOF

CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY BINDING TO CD 300C ANTIGEN OR RECEPTOR THEREOF

PEPTIDES AND METHODS OF USE THEREOF IN TREATING UVEITIS

TOPICAL CYCLOSPORINE FOR TREATING PSORIASIS AND OTHER AILMENTS

METHODS AND COMPOSITIONS FOR INHIBITING GLYOXALASE 1 (GLO1)

USE OF HEPARIN TO PROMOTE TYPE 1 INTERFERON SIGNALING

METHODS FOR THE TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY (AATD)

Drug Delivery Composition Comprising a Self-Assembled Gelator

Treatment of Cancer

Pharmaceutical composition for inhibiting the infectivity of lipid bilayer viruses, treating associated diseases and their complications

THE USE OF PARAXANTHINE TO REDUCE EXERCISE-INDUCED MENTAL FATIGUE

Pyrazole pyrimidine compounds and uses thereof

COMBINATORIAL THERAPY TARGETING PARP1 AND RTK

INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7)

IRAK4 KINASE INHIBITOR AND PREPARATION METHOD THEREFOR

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND DISORDERS

REBAMIPIDE FOR USE IN PROPHYLAXIS AND TREATMENT OF CELIAC DISEASE

OPHTHALMIC COMPOSITIONS

Mi-2β inhibitor as an immunotherapy agent

COMBINATION THERAPY FOR PROLIFERATIVE CONDITIONS

AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF

SYSTEM FOR ENHANCING THERAPEUTIC COMPLIANCE OF THE ANTI-CANCER COMPOUND E7766

METHODS OF REDUCING DISEASE FLARES

Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound

Method of simultaneously treating viral disease caused coronavirus, its variants and mutants using a pharmaceutical micronutrient composition

Compositions comprising cannabinoids and methods of use

COMBINATION THERAPY AND BIOMARKER INDICATING EFFICACY THEREOF

TREATMENT OF LONG HAULERS SYNDROME WITH NICLOSAMIDE

TREATMENT OF FERROPTOSIS

ESKETAMINE FOR THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER, INCLUDING SUICIDALITY

TRANS-ANETHOLE ((E)-1-METHOXY-4- (1-PROPENYL) BENZENE), A NEW AND POTENT INHIBITOR OF PROLYL ENDOPEPTIDASE

METHODS OF TREATING METABOLIC SYNDROME RELATED CONDITIONS USING RETINOIC ACID RECEPTOR AGONISTS

Phosphodiesterase-4 inhibitor combinations, methods of making, and methods of use thereof

Cosmetic Compositions for Skin Health and Methods of Using Same

COMPOUNDS AND METHODS FOR INHIBITING CANCERS VIA REST INHIBITION

PSGL-1 Antagonists and Uses Thereof

METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR

Treatment of Cancers Lacking EGFR- Activating Mutations

COMBINATION THERAPY WITH A MEK INHIBITOR, A PD-1 AXIS INHIBITOR, AND A VEGF INHIBITOR

Anti-TMEFF1 antibodies and antibody drug conjugates

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH COLLAGEN BINDING DRUG CARRIERS

Artificial alphavirus-derived RNA replicon expression systems

Immunotherapy against several tumors including lung cancer

Cyclic deoxyribonucleotide compounds

Neprilysin inhibitors

Toll-like receptor antagonist compounds and methods of use

4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS

ISOXAZOLE-3-CARBOXAMIDE DERIVATIVES AND THEIR USE FOR TREATMENT OF DISEASES CAUSED BY VIRUS INFECTION

GLP-1R modulating compounds

5-HETEROARYL-PYRIDIN-2-AMINE COMPOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS

HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS

Pyrrolobenzodiazepine antibody conjugates

Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions

METHODS FOR TREATMENT USING PHTHALOCYANINE DYE-TARGETING MOLECULE CONJUGATES

ALK1 receptor and ligand antagonists and uses thereof

METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TUMOR OR CANCER, AND APPLICATION THEREOF

TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA

METHODS FOR TREATING MUSCULAR DYSTROPHY USING INHIBITORY OLIGONUCLEOTIDES TO CD49D

Pharmaceutical compositions comprising substituted nucleotides and nucleosides for treating viral infections

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SWI-SNF MUTANT TUMORS

PULMONARY PHARMACEUTICAL FORMULATIONS

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER